Affiliation:
1. Department of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USA
2. Department of Chemistry and Biochemistry, University of Wisconsin-La Crosse, La Crosse, WI 54601, USA
Abstract
Background: Staphylococcus aureus is a leading cause of skin and bloodstream infections in humans. Antibiotic resistant strains of S. aureus continue to be a problem in treating patients that are infected, so treatment options are needed. A drug discovery project identified SK-03-92 as a novel anti-staphylococcal drug, but the SK-03-92 mechanism of action is unknown. We hypothesized that a lethal factor was being released by the bacteria that killed siblings. Methods: In this study, filtration through molecular weight cut-off filters as well as boiling, trypsin treatment, and proteinase K treatment were used to ascertain what the lethal factor was released by SK-03-92 treated S. aureus cells. Results: Filtration through molecular weight cut-off filters demonstrated the lethal factor released by SK-03-92 treated S. aureus cells had a molecular cut-off between 10,000 Da and 30,000 Da that killed fresh S. aureus cells but was not released by untreated cells. Through proteinase K digestion, trypsin digestion, and boiling experiments, the lethal factor was shown to be a protein. Further experiments are needed to identify what proteins released following SK-03-92 treatment cause the death of S. aureus cells. Conclusions: The data show that SK-03-92 treatment causes S. aureus to release a lethal factor protein that kills S. aureus cells, suggesting a new mechanism of action for an antibacterial drug.
Funder
UW-System-WiSys
UWL RSEL
UWL Undergraduate Research
Reference49 articles.
1. Suaya, J.A., Mera, R.M., Cassidy, A., O’Hara, P., Amrine-Madsen, H., Burstin, S., and Miller, L.G. (2014). Incidence and cost of hospitalization associated with Staphylococcus aureus skin and soft tissue infections in the United States from 2001 through 2009. BMC Infect. Dis., 14.
2. The changing epidemiology of methicillin-resistant Staphylococcus aureus hospitalizations in the United States: A national observational study;Klein;Am. J. Epidemiol.,2013
3. Trends in methicillin-resistant Staphylococcus aureus hospitalizations in the United States, 2010–2014;Klein;Clin. Infect. Dis.,2017
4. WHO (World Health Organization) (2024, February 22). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report, Available online: https://www.who.int/publications/i/item/9789240027336.
5. Methicillin-resistant Staphylococcus aureus;Lee;Nat. Rev. Dis. Primers,2018